| Old Articles: <Older 28411-28420 Newer> |
|---|
 |
The Motley Fool
January 31, 2008
Brian Lawler |
Don't Forget Roche Roche, the largest biopharma, by market capitalization, had a terrific 2007. Since it is not publicly listed on the major U.S. stock exchanges, the company never gets its fair share of attention.   |
The Motley Fool
January 31, 2008
Brian Lawler |
A Zettlement for Zyprexa? Eli Lilly may be close to resolving a government lawsuit over improper marketing. |
The Motley Fool
January 31, 2008
David Lee Smith |
U.S. Steel's Sharp Slide U.S. Steel has its share of problems. Don't let them become yours. |
The Motley Fool
January 31, 2008
Brian Orelli |
Investing Before the IPO If the idea of investing pre-IPO excites you, but you don't want to invest directly in a venture capital fund, there's a way to get in on the new company action by buying publicly traded companies: Many drug companies have venture capital arms. |
The Motley Fool
January 31, 2008
Alyce Lomax |
Starbucks Stinks? Starbucks first-quarter earnings were lukewarm at best. Releasing lukewarm net income growth of 2% and 1% same-store sales, the numbers weren't even close to what long-time fans are used to seeing. |
The Motley Fool
January 31, 2008
Rich Duprey |
Candela Investors Burned Again The aesthetic-laser maker continues its string of disappointing quarters. |
The Motley Fool
January 31, 2008
Tom Hutchinson |
JetBlue Back in the Black The airline posts its first profit in three years. |
The Motley Fool
January 31, 2008
David Lee Smith |
Three More on the Housing Slide Three more homebuilders, Meritage Homes, Pulte, and Centex, have reported, all demonstrating that builders are still hurting. |
The Motley Fool
January 31, 2008
Brian Orelli |
Wyeth Calls Teva's Bluff Wyeth launches a generic version of its own heartburn drug. |
The Motley Fool
January 31, 2008
Tim Beyers |
Michael Dell Plans Android Rumors of a Dell smartphone abound. |
| <Older 28411-28420 Newer> Return to current articles. |
